ライフサイエンスコーパス: erythematous

1 evaluated as the percent of sites considered erythematous.

2 ma, rheumatoid arthritis, and systemic lupus erythematous.

3 d in autoimmune diseases like systemic lupus erythematous.

4 cally, the gingival papillary overgrowth was erythematous and edematous, with a propensity toward spo

5 h perennial allergic rhinitis typically have erythematous and inflamed turbinates with serous secreti

6 skin over the lateral part of the breast was erythematous and showed the presence of prominent superf

7 Nine of them had infiltrated itchy erythematous and vesiculous plaques at the injection sit

8 ysfunctional in patients with systemic lupus erythematous, and thus resemble promising candidates for

9 All nine cats developed raised, erythematous areas at the site of inoculation within 72

10 "Macroscopically visible sterile pustules on erythematous base and not restricted to the acral region

11 Skin lesions with pruritic vesicles on an erythematous base with surrounding swelling and edema we

12 3 AI diseases and WBC counts: systemic lupus erythematous (Beta = - 0.05 [95% CI, - 0.06, - 0.03]), m

13 Clinical examination revealed a large, erythematous, bluish, and non-tender swelling in the lef

14 teristic lesions with central pearly hue and erythematous border were seen.

15 The incidence of erythematous candidiasis (EC), pseudomembranous candidia

16 Cutaneous Lupus Erythematous (CLE) is an autoimmune disease in which pat

17 e found: cellulitis on days 1-3, nonspecific erythematous condition on days 2-4, "other complications

18 d therapy, neutrophilia, and abrupt onset of erythematous cutaneous lesions.

19 zed by hyperkeratotic follicular papules and erythematous desquamative plaques.

20 ating, maculopapular, papulopustular, and/or erythematous diffuse rash.

21 of trauma and scar formation presented with erythematous, dry plaques with fine crackling involving

22 The lesions had raised and erythematous edges over the nostril and a median (range)

23 Twenty-four hours after injection, erythematous, elevated plaques were observed in all huma

24 hosis nigricans, carcinoid syndrome, unusual erythematous eruptions such as erythema gyratum repens,

25 patients who present with other, more common erythematous eruptions.

26 -17C in KCs develop well-demarcated areas of erythematous, flakey involved skin adjacent to areas of

27 leukemic conversion and with worsening of an erythematous generalized papular rash, he received one d

28 A 33-year-old woman presented with an erythematous gingival mass involving the anterior maxill

29 Patients with subacute and Discoid Lupus Erythematous had elevated Interferon score, about a thir

30 nful, black, crusted ulcer with a peripheral erythematous halo was noted in the left popliteal fossa;

31 herapies for the treatment of systemic lupus erythematous, including hematopoietic stem cell transpla

32 Systemic lupus erythematous is a clinically and pathogenetically hetero

33 Systemic lupus erythematous is a heterogeneous autoimmune disease with

34 -week-old male who presented with a swollen, erythematous left index finger and elevated serum marker

35 (r = 0.985; P = .006) but not urticarial and erythematous lesions (r = 0.632; P = .23).

36 Skin biopsy of the erythematous lesions showed dense neutrophilic infiltrat

37 P180 NC16A IgE antibodies with urticarial or erythematous lesions was observed (r = 0.481; P = .31),

38 erized by a spectrum of changes ranging from erythematous maculae to vascular tumors, by the presence

39 d is frequently associated with an overlying erythematous, macular rash that, together with the myalg

40 , followed by the development of one or more erythematous maculopapular lesions that evolve over the

41 nonhematologic toxicity consisted of grade 3 erythematous maculopapular rash observed in one patient

42 llness characterised by fever, a generalised erythematous maculopapular rash, and lymphadenopathy.

43 nd TV005 causes a mild, relatively localized erythematous maculopapular skin rash in most dengue-naiv

44 Two patients developed erythematous, maculopapular to papular eruptions confine

45 ith a history of EDS type III presented with erythematous mucogingival lesions.

46 Neuromyelitis optica, systemic lupus erythematous, neurosarcoidosis, infections, and cerebrov

47 k, thighs, and buttocks and multiple raised, erythematous nodules on both shins.

48 evealed multifocal lesions that consisted of erythematous nodules on the leg and foot in case 1 and s

49 The rash consisted of mild erythematous, non-scaling patches with scattered non-pal

50 A 21-year-old man presented with multiple erythematous nonfollicular papules partially confluent t

51 16 (94.1%) had bilaterally localized distal erythematous or cyanotic lesions.

52 g disease characterized by tense blisters on erythematous or normal skin that predominantly affects t

53 Class 2 mobility of tooth #28 along with an erythematous, papillary appearance of the lingual gingiv

54 ossa; the ulcer had begun as an asymptomatic erythematous papule 1 week previously.

55 0%]) had a clinical morphology consisting of erythematous papules with scale in a variety of distribu

56 n blood nocturnally, causing linear pruritic erythematous papules.

57 py as multiple ulcers, polypoidal growth and erythematous patches and has shown to share clinicopatho

58 lesions in 90 (78%), polypoidal in 29 (25%), erythematous patches in 3 (2.5%) and petechial spots in

59 ated with the occurrence of rapidly changing erythematous patches with prominent, circinate, or gyrat

60 Skin biopsy of an erythematous plaque on the thigh demonstrated a suppurat

61 The following day, erythematous plaques appeared all over his body, gradual

62 is a self-limited condition, manifesting as erythematous plaques or nodules after cold exposure, tha

63 The BP IgE-induced erythematous plaques were reminiscent of those clinicall

64 matic episodic flares of annular, polycyclic erythematous plaques with scale, which coalesce to invol

65 Erythematous plaques, 0.5 to 2.5 cm in diameter, were pr

66 y skin disease characterized by wet, oozing, erythematous, pruritic lesions in the acute stage and xe

67 and trunk (sometimes umbilicated), and firm erythematous purpuric or pigmented infiltrated plaques a

68 therapy for chronic back pain who developed erythematous, purpuric plaques at the site of ice-pack a

69 cases, rash (n=440)-particularly generalised erythematous rash (n=334)-fever (n=333), leukopenia (n=2

70 logical diseases and are characterized by an erythematous rash and severe itch.

71 adjuvanted vaccine group developed a grade 3 erythematous rash at the injection site.

72 He also developed a maculopapular and erythematous rash in the groin, genitalia, and buttocks.

73 ber and December 2011, a persistent, raised, erythematous rash in the tattoo area developed in 19 per

74 entlemen presented with generalised pruritic erythematous rash on trunk and extremities.

75 t, became lymphocytopenic, and developed the erythematous rash typical of CDV.

76 enia, decreased activity, conjunctivitis, an erythematous rash typical of distemper, CNS signs, and v

77 Omenn syndrome requires a generalized erythematous rash, absent transplacentally acquired mate

78 cluding diarrhea, alopecia, and desquamating erythematous rash.

79 Erythematous rashes that are suggestive of early Lyme di

80 gray-white fibrin layer and encircled by an erythematous ring.

81 sis rubra pilaris (PRP) refers to a group of erythematous, scaling dermatologic conditions that have

82 g inflammatory skin disease characterized by erythematous scaly plaques.

83 ntermittent bouts of annular and polycyclic, erythematous, scaly plaques on the trunk and proximal ex

84 The lesions were erythematous, scaly, and crusted, always affecting the s

85 Such manifestations become erythematous-scaly as the condition progresses to the su

86 e criteria for diagnosis are (1) presence of erythematous-scaly, exudative, and crusted lesions invol

87 ations between: (1) oral mucosal disease and erythematous skin disease, (2) salivary gland dysfunctio

88 -cell-driven disorder characterized by thick erythematous skin plaques.

89 shortened life spans, prominent scaling and erythematous skin with alopecia, and occasional papillom

90 Patients with systemic lupus erythematous (SLE) display dysregulated B cell responses

91 targeted therapy approved for systemic lupus erythematous (SLE) in over 50 y.

92 Systemic lupus erythematous (SLE) is a female-predominant disease chara

93 Systemic lupus erythematous (SLE) is a heterogeneous autoimmune disease

94 ti-RNA autoantibodies both in systemic lupus erythematous (SLE) patients and in murine models of lupu

95 ost serious manifestations of systemic lupus erythematous (SLE).

96 sely associated with CLE than Systemic Lupus Erythematous (SLE).

97 Both had erythematous to cyanotic and hyperplastic gingiva.

98 The clinical manifestations include erythematous to purpuric plaques with a livedolike appea

99 and IgM/IgG immune complex vasculitis, lupus erythematous tumidus, Wells syndrome, erythema multiform

100 wing criteria: (i) presence of ulcer(s) with erythematous/violaceous undermining wound borders, (ii)